ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ

Abstract excerpt

Preeclampsia (PE) is a major cause of maternal mortality and morbidity worldwide. Although there has been great progress in the understanding of PE, the exact cause for the disease development is still unclear. Recently, studies showed that genetic deletion of ELABELA (ELA, also known as APELA) could induce PE-like symptoms in mice. However, the role of ELA in the disease development of PE remains elusive. Our...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apelin-related biomedical research
• Share to Cardiovascular, Neuropeptides, and Oxidative Stress Research
• Share to Pregnancy and preeclampsia studies